首页> 外国专利> REMEDIES FOR MYELOMA TO BE USED TOGETHER WITH NITROGEN MOSTAZA ANTITUMORAL AGENTS.

REMEDIES FOR MYELOMA TO BE USED TOGETHER WITH NITROGEN MOSTAZA ANTITUMORAL AGENTS.

机译:与骨髓MOSTAZA抗肿瘤剂一起使用的骨髓瘤的补救措施。

摘要

A THERAPEUTIC AGENT FOR MYELOMA IS DESCRIBED, UNDERSTANDING THE COMBINED USE OF AN NITROGEN MOSTAZA-BASED ANTI-BANK AGENT AND AN ANTI-IL-6 RECEIVING ANTIBODY. A THERAPEUTIC AGENT FOR MYELOMA THAT INCLUDES ANTIBODY OF ANTI-IL-6 RECEIVERS IS EXPOSED, TO USE IN COMBINATION WITH AN NITROGEN MOSTAZA-BASED ANTI-TARGET AGENT; A THERAPEUTIC AGENT FOR MYELOMA UNDERSTANDING AN NITROGEN MOSTAZA-BASED ANTI-BANK AGENT TO USE IN COMBINATION WITH ANTI-IL-6 RECEIVER ANTIBODY; AND A THERAPEUTIC AGENT FOR MYELOMA THAT INCLUDES AN ANTI-BANKER AGENT BASED ON NITROGEN MOSTAZA AND AN ANTIBODY OF ANTI-IL6 RECEIVERS.
机译:描述了一种用于骨髓瘤的治疗剂,理解了基于氮基莫桑扎的抗细胞剂和抗IL-6受体抗体的联合使用。公开了一种治疗骨髓炎的药物,该药物包括抗IL-6受体的抗体,可与基于氮MO的抗靶标药物联合使用;骨髓瘤的治疗剂,了解一种基于氮莫斯塔萨的抗银行代理与抗IL-6受体抗体结合使用;以及一种用于骨髓瘤的治疗剂,其包括基于氮转移蛋白和抗IL6受体抗体的抗癌剂。

著录项

  • 公开/公告号ES2263178T3

    专利类型

  • 公开/公告日2006-12-01

    原文格式PDF

  • 申请/专利权人 CHUGAI SEIYAKU KABUSHIKI KAISHA;

    申请/专利号ES19970928507T

  • 发明设计人 NAKAMURA AKITO;AKAMATSU KENICHI;

    申请日1997-06-27

  • 分类号A61K39/395;C12N15/02;A61K31/13;A61K31/131;A61K31/19;A61K31/195;A61K31/197;A61K31/198;A61K31/305;A61K31/505;A61K31/513;A61K31/675;A61K38;A61P35;A61P43;C07C229/42;C07C291/04;C07D239/54;C07F9/6584;C07K16/28;C12N1/21;C12P21/08;

  • 国家 ES

  • 入库时间 2022-08-21 20:54:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号